A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 03 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
- 10 Jun 2017 Biomarkers information updated
- 21 Jul 2016 Status changed from recruiting to active, no longer recruiting.